Log In Sign up
The largest database of trusted experimental protocols

Phospho aktser473 antibody

Manufactured by R&D Systems
Visit Supplier

The Phospho-AKTSer473 antibody is a primary antibody that specifically recognizes AKT protein phosphorylated at serine 473. It can be used to detect and quantify the levels of phosphorylated AKT in various samples, such as cell lysates, by techniques like Western blotting.

Automatically generated - may contain errors

Lab products found in correlation

Phospho nf κb p65 ser536, by Cell Signaling Technology (2 mentions) Phospho rb ser807 811, by Cell Signaling Technology (2 mentions) Phospho mtor ser2481, by Cell Signaling Technology (2 mentions) Phospho mek, by Cell Signaling Technology (2 mentions) Tnf α, by R&D Systems (2 mentions) Phospho erk, by Cell Signaling Technology (2 mentions) Nf κb p65, by Santa Cruz Biotechnology (2 mentions) Phospho foxo1, by Cell Signaling Technology (2 mentions) Pd0332991, by Selleck Chemicals (2 mentions) Phospho s6rb, by Cell Signaling Technology (2 mentions) P21 specific, by Santa Cruz Biotechnology (2 mentions) Phospho p130 antiserum, by Abcam (2 mentions) Phospho rb ser780, by Cell Signaling Technology (2 mentions) U0126, by Selleck Chemicals (2 mentions) Phospho 4ebp1, by Cell Signaling Technology (2 mentions) 4e bp1, by Cell Signaling Technology (2 mentions) Gapdh, by Santa Cruz Biotechnology (2 mentions) Cyclin d1, by Santa Cruz Biotechnology (2 mentions)

2 protocols using phospho aktser473 antibody

1

Signaling Pathway Profiling in Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
TNF-a was purchased from R&D Systems (catalog #210-TA/CF). ON123300 was obtained from Onconova Therapeutics, Inc. PD0332991, U0126 and QNZ were purchased from Selleckchem. Antibodies directed against PARP (catalog #9542), CASPASES 3 (catalog #9665), 7 (catalog #9492) and 9 (catalog #9502), phospho-RbSer780 (catalog #9307), Rb (catalog #9309), phospho-mTORSer2481 (catalog #2974), mTOR (catalog #4517, phospho-4EBP1 (catalog #9459), 4EBP1 (catalog #9644), phospho-S6RB (catalog #2211), S6RB (catalog #2317), phospho-FOXO1 (catalog #9461), phospho-ERK (catalog #4370), ERK (catalog #9107), phospho-MEK (catalog #9154), MEK (catalog #4694), phospho-NF-κB p65Ser536 (catalog #3033), and phospho-RbSer807/811 (catalog #9308) were obtained from Cell Signaling Technologies. GAPDH (catalog #SC-47724), AKT (catalog #SC-1618), p130 (catalog #SC-317), CDK4 (catalog #SC-260), CDK2 (catalog #SC-163), CYCLIN D1 (catalog #SC-8396), NF-κB p65 (catalog #sc-8008) and p21-specific (catalog #SC-756) antisera were purchased from Santa Cruz Biotechnology. The phospho-AKTSer473 antibody was purchased from R&D Systems (catalog #AF-887). Phospho-p130 antiserum was obtained from Abcam (catalog #AB68136).
Divakar S.A., Reddy M.V., Cosenza S.C., Baker S.J., Perumal D., Antonelli A.C., Brody J., Akula B., Parekh S, & Reddy E.P. (2015). Dual Inhibition of CDK4/Rb and PI3K/AKT/mTOR Pathways by ON123300 Induces Synthetic Lethality in Mantle Cell Lymphomas. Leukemia, 30(1), 86-93.
+ Open protocol
+ Expand
2

Signaling Pathway Profiling in Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
TNF-a was purchased from R&D Systems (catalog #210-TA/CF). ON123300 was obtained from Onconova Therapeutics, Inc. PD0332991, U0126 and QNZ were purchased from Selleckchem. Antibodies directed against PARP (catalog #9542), CASPASES 3 (catalog #9665), 7 (catalog #9492) and 9 (catalog #9502), phospho-RbSer780 (catalog #9307), Rb (catalog #9309), phospho-mTORSer2481 (catalog #2974), mTOR (catalog #4517, phospho-4EBP1 (catalog #9459), 4EBP1 (catalog #9644), phospho-S6RB (catalog #2211), S6RB (catalog #2317), phospho-FOXO1 (catalog #9461), phospho-ERK (catalog #4370), ERK (catalog #9107), phospho-MEK (catalog #9154), MEK (catalog #4694), phospho-NF-κB p65Ser536 (catalog #3033), and phospho-RbSer807/811 (catalog #9308) were obtained from Cell Signaling Technologies. GAPDH (catalog #SC-47724), AKT (catalog #SC-1618), p130 (catalog #SC-317), CDK4 (catalog #SC-260), CDK2 (catalog #SC-163), CYCLIN D1 (catalog #SC-8396), NF-κB p65 (catalog #sc-8008) and p21-specific (catalog #SC-756) antisera were purchased from Santa Cruz Biotechnology. The phospho-AKTSer473 antibody was purchased from R&D Systems (catalog #AF-887). Phospho-p130 antiserum was obtained from Abcam (catalog #AB68136).
Divakar S.A., Reddy M.V., Cosenza S.C., Baker S.J., Perumal D., Antonelli A.C., Brody J., Akula B., Parekh S, & Reddy E.P. (2015). Dual Inhibition of CDK4/Rb and PI3K/AKT/mTOR Pathways by ON123300 Induces Synthetic Lethality in Mantle Cell Lymphomas. Leukemia, 30(1), 86-93.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!